DCM
IQMDU

Difesa Capital Management’s Intelligent Medicine Acquisition Corp. Unit IQMDU Stock Holding History

Difesa Capital Management’s Portfolio IQMDU Stock Details IQMDU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-100,000
Closed -$1.01M – 293
2022
Q3 		$1.01M Hold
100,000
– – 0.52% 63
2022
Q2 		$1M Hold
100,000
– – 0.57% 58
2022
Q1 		$1.01M Hold
100,000
– – 0.51% 56
2021
Q4 		$1.02M Buy
+100,000
New +$1.01M 0.69% 47

Other funds holding IQMDU

YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.95% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.72% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.34% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
TAM
Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return

Difesa Capital Management's IQMDU Position: Q4 2022 in Review

Difesa Capital Management sold out of Intelligent Medicine Acquisition Corp. Unit (IQMDU) in Q4 2022, closing a stake of 100,000 shares — an estimated $1.01M sold.

Difesa Capital Management first reported a position in IQMDU in Q4 2021 and held it in 4 quarters. The position peaked at $1.02M in Q4 2021. 13 funds tracked by Wall St. Rank hold IQMDU as of Q4 2022.

  • Difesa Capital Management reported no remaining Intelligent Medicine Acquisition Corp. Unit position as of Q4 2022 after selling out during the quarter.
  • Difesa Capital Management sold 100,000 Intelligent Medicine Acquisition Corp. Unit shares in Q4 2022, an estimated $1.01M.
  • Difesa Capital Management first reported a position in Intelligent Medicine Acquisition Corp. Unit in Q4 2021 and held it in 4 quarters.
  • Difesa Capital Management's Intelligent Medicine Acquisition Corp. Unit position peaked at $1.02M in Q4 2021.
  • 13 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Unit as of Q4 2022.

Based on Difesa Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.